학술논문
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of Latin American patients with rheumatoid arthritis: Pooled efficacy and safety analyses of Phase 3 and long-term extension studies
Document Type
Article
Author
Source
In Reumatología clínica (English Edition) July-August 2017 13(4):201-209
Subject
Language
ISSN
2173-5743